ArticleTargeted oncology2024

Correction to: Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.

Yuan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.